Patent Drafting Pointers From Fed. Circ. COVID Test Ruling

By Irah Donner ( March 27, 2025, 6:04 PM EDT) -- In DNA Genotek Inc. v. Spectrum Solutions LLC,[1] the U.S. Court of Appeals for the Federal Circuit held on Feb. 14 that the deletion of an embodiment with the reagent compartment in the cap in the nonprovisional application that was present in the earlier filed provisional application demonstrated an intent to limit the nonprovisional application to a device with a reagent compartment in the containment vessel, and not in the cap....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as